Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna L, Evans ML, Neupane S, et al.
N Engl J Med. Pub. online 5 Oct 2022.
Leggi
Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis
Yang S, Zhao L, Mi Y, He W
Diabetes Obes Metab. 2022;24(11):2159-2168.
Leggi
Prediabetes diagnosis is associated with the progression of coronary artery calcification: The Kangbuk Samsung Health Study
Choi IY, Chang Y, Cho Y, et al.
Diabetes Obes Metab. 2022;24(11):2118-2126.
Leggi
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
Gregory GA, Robinson TIG, Linklater SE, et al.
Lancet Diabetes Endocrinol. 2022;10(10):741-760.
Leggi
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Heerspink HJL, Sattar N, Pavo I, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00243-1.
Leggi
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence
Khunti K, Aroda VR, Bhatt DL, et al.
Diabetes Obes Metab. 2022;24(11):2071-2080.
Leggi
Multicenter, randomized trial of a bionic pancreas in type 1 diabetes
Russell SJ, Beck RW , Damiano ER, et al.
N Engl J Med 2022;387:1161-1172.
Leggi
Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin a1c: the whitehall ii cohort study
Tabák AG, Brunner EJ, Lindbohm JV, et al.
Circulation. 2022;146(13):995-1005.
Leggi
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries
Birkebaek NH, Kamrath C, Grimsmann JM, et al.
Lancet Diabetes Endocrinol. Pub. online 3 Oct 2022.
Leggi
Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study
Liu N, Wang G, Liu C, et al.
Diabetes Obes Metab. Pub. online 1 Oct 2022.
Leggi